Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by WOLTHUIS, O. L.
Right arrow Articles by VANWERSCH, R. A. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by WOLTHUIS, O. L.
Right arrow Articles by VANWERSCH, R. A. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1984 Oxford University Press

research-article

Behavioral Changes in the Rat after Low Doses of Cholinesterase Inhibitors

O. L. WOLTHUIS and R. A. P. VANWERSCH

Medical Biological Laboratory P.O. Box 45, 2280 AA Rijswijk, The Netherlands

Behavioral Changes in the Rat after Low Doses of Cholinestease Inhibitors. WOLTHUIS, O. L., AND VANWERSCH, R. A. P. (1984). Fundam. Appl. Toxicol. 4, S195–S208. In rats the acute effects of low doses of five cholinesterase (ChE) inhibitors were investigated in six behavioral tests. Considerable differences were found between the inhibitors studied. TEPP and sarin at doses up to 30% LD50 were without effects. In contrast, soman, physostigmine, and pyridostigmine caused effects at dose levels which did not produce overt symptoms and did not affect running speed and simple coordinated locomotion. Soman (<3% LD50), physostigmine (<4.5% LD50), and pyridostigmine (<10% LD50) interfered with two-way shuttlebox avoidance learning, open field behavior, and complex coordinated movements (hurdle-stepping task). Tests of retention in a passive avoidance learning test appeared less sensitive. It is concluded that paradigms that involve higher CNS structures and require motor activity are sensitive to some ChE inhibitors at doses far below those that cause overt symptoms. The individual characteristics of ChE inhibitors play an important role. In contrast to TEPP and sarin, soman has a predominantly central effect. Further, the finding that pyridostigmine was also effective at unexpectedly low dose levels suggests that this compound may have more central actions than hitherto accepted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.